These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 21760596)

  • 1. p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53.
    Melino G
    Cell Death Differ; 2011 Sep; 18(9):1487-99. PubMed ID: 21760596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p63 steps into the limelight: crucial roles in the suppression of tumorigenesis and metastasis.
    Su X; Chakravarti D; Flores ER
    Nat Rev Cancer; 2013 Feb; 13(2):136-43. PubMed ID: 23344544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PERP-ing into diverse mechanisms of cancer pathogenesis: Regulation and role of the p53/p63 effector PERP.
    Roberts O; Paraoan L
    Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188393. PubMed ID: 32679166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant p53 regulates Dicer through p63-dependent and -independent mechanisms to promote an invasive phenotype.
    Muller PA; Trinidad AG; Caswell PT; Norman JC; Vousden KH
    J Biol Chem; 2014 Jan; 289(1):122-32. PubMed ID: 24220032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutant p53/let-7i-axis-regulated gene network drives cell migration, invasion and metastasis.
    Subramanian M; Francis P; Bilke S; Li XL; Hara T; Lu X; Jones MF; Walker RL; Zhu Y; Pineda M; Lee C; Varanasi L; Yang Y; Martinez LA; Luo J; Ambs S; Sharma S; Wakefield LM; Meltzer PS; Lal A
    Oncogene; 2015 Feb; 34(9):1094-104. PubMed ID: 24662829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of p63 and induction of EMT by mutant Ras in mammary epithelial cells.
    Yoh KE; Regunath K; Guzman A; Lee SM; Pfister NT; Akanni O; Kaufman LJ; Prives C; Prywes R
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6107-E6116. PubMed ID: 27681615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant p53 uses p63 as a molecular chaperone to alter gene expression and induce a pro-invasive secretome.
    Neilsen PM; Noll JE; Suetani RJ; Schulz RB; Al-Ejeh F; Evdokiou A; Lane DP; Callen DF
    Oncotarget; 2011 Dec; 2(12):1203-17. PubMed ID: 22203497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
    Murray-Zmijewski F; Lane DP; Bourdon JC
    Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activating transcription factor 3 protein suppresses the oncogenic function of mutant p53 proteins.
    Wei S; Wang H; Lu C; Malmut S; Zhang J; Ren S; Yu G; Wang W; Tang DD; Yan C
    J Biol Chem; 2014 Mar; 289(13):8947-59. PubMed ID: 24554706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Diverse Functions of Mutant 53, Its Family Members and Isoforms in Cancer.
    Hall C; Muller PAJ
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel approach to cancer treatment using structural hybrids of the p53 gene family.
    Sasaki Y; Oshima Y; Koyama R; Tamura M; Kashima L; Idogawa M; Yamashita T; Toyota M; Imai K; Shinomura Y; Tokino T
    Cancer Gene Ther; 2012 Nov; 19(11):749-56. PubMed ID: 22956039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p63 at the Crossroads between Stemness and Metastasis in Breast Cancer.
    Gatti V; Bongiorno-Borbone L; Fierro C; Annicchiarico-Petruzzelli M; Melino G; Peschiaroli A
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31159154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p63 expression defines a lethal subset of muscle-invasive bladder cancers.
    Choi W; Shah JB; Tran M; Svatek R; Marquis L; Lee IL; Yu D; Adam L; Wen S; Shen Y; Dinney C; McConkey DJ; Siefker-Radtke A
    PLoS One; 2012; 7(1):e30206. PubMed ID: 22253920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OCT4 as a target of miR-34a stimulates p63 but inhibits p53 to promote human cell transformation.
    Ng WL; Chen G; Wang M; Wang H; Story M; Shay JW; Zhang X; Wang J; Amin AR; Hu B; Cucinotta FA; Wang Y
    Cell Death Dis; 2014 Jan; 5(1):e1024. PubMed ID: 24457968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100A2 is a BRCA1/p63 coregulated tumour suppressor gene with roles in the regulation of mutant p53 stability.
    Buckley NE; D'Costa Z; Kaminska M; Mullan PB
    Cell Death Dis; 2014 Feb; 5(2):e1070. PubMed ID: 24556685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic roles of EMT-inducing transcription factors.
    Puisieux A; Brabletz T; Caramel J
    Nat Cell Biol; 2014 Jun; 16(6):488-94. PubMed ID: 24875735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A microRNA-dependent circuit controlling p63/p73 homeostasis: p53 family cross-talk meets therapeutic opportunity.
    Ory B; Ellisen LW
    Oncotarget; 2011 Mar; 2(3):259-64. PubMed ID: 21436470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dominant-negative interplay between p53, p63 and p73: A family affair.
    Billant O; Léon A; Le Guellec S; Friocourt G; Blondel M; Voisset C
    Oncotarget; 2016 Oct; 7(43):69549-69564. PubMed ID: 27589690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintaining epithelial stemness with p63.
    Melino G; Memmi EM; Pelicci PG; Bernassola F
    Sci Signal; 2015 Jul; 8(387):re9. PubMed ID: 26221054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The microRNA feedback regulation of p63 in cancer progression.
    Lin C; Li X; Zhang Y; Guo Y; Zhou J; Gao K; Dai J; Hu G; Lv L; Du J; Zhang Y
    Oncotarget; 2015 Apr; 6(11):8434-53. PubMed ID: 25726529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.